Ramezani Tehrani, Fahimeh
,
Behboudi-Gandevani, Samira
Abedini, Mehrandokht
Soleymani-Dodaran, Masoud
Khalili, Davood
Farzadfar, Farshad
Hoseinpanah, Farhad
Hadaegh, Farzad
Valizadeh, Majid
Torkestani, Farahnaz
Abdollahi, Zahra
Bakhshandeh, Marzieh
Bidhendi Yarandi, Razieh
Zokaee, Mehdi
Bidarpour, Farzam
Javanbakht, Mehdi
Nabipour, Iraj
Mansournia, Mohammad Ali
Nasli Esfahani, Ensieh
Ostovar, Afshin
Azizi, Fereidoun
Najari, Abbas
Khajeian, Abdolmohhamad
Anaraki, Azita
Ghazaghi, Fariba
Lahouni, Forouzan
Kalantari, Forouzandeh
Fallah, Hossein
Kordi, Khadije
Saed, Lotfollah
Norooozzadeh, Mahsa
Farahmand, Maryam
Rostami Dovom, Marzieh
Hedayati, Mehdi
Mehdizade, Mehdi
Amiri, Mina
Lotfi, Mohammad Hassan
Motlagh, Mohammad-Esmaeil
Bashghareh, Mozhgan
Zamanipour, Nosrat
Mirmiran, Parvin
Sadeghian Sharif, Saeid
Shahraz, Saeid
Khari, Samareh
Alishahi, Sedigheh
Shahgheibi, Shole
Nazarpour, Sima
Mehrabi, Yadollah
Ghaedmohammadi, Zahra
Clinical trials referenced in this document:
Documents that mention this clinical trial
Cost effectiveness of different screening strategies for gestational diabetes mellitus screening: study protocol of a randomized community non-inferiority trial
https://doi.org/10.1186/s13098-019-0493-z
Funding for this research was provided by:
National Institute for Medical Research Development (IR.NIMAD.REC.1394.013)
Article History
Received: 19 August 2019
Accepted: 9 November 2019
First Online: 18 December 2019
Ethics approval and consent to participate
: The protocol was approved by the national ethics committee of the National Institute for Medical Research Development (Approval number: IR.NIMAD.REC.1394.013). In addition, the Iranian Ministry of Health and Medical Education (MoHME) approved the study protocol and pre specified GDM modalities were made available to all those provinces as mandatory guidelines. This field trial has been registered in Iranian Registry of Clinical Trials (Trial Registration: IRCT138707081281N1).
: Not applicable.
: The authors declare that they have no competing interests.